Morgan Stanley Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price objective reduced by Morgan Stanley from $175.00 to $168.00 in a research report issued on Friday,MarketScreener reports. Morgan Stanley’s target price would indicate a potential upside of 27.92% from the stock’s current price. A number of other research analysts have also recently issued reports on […]